Related by context. Frequent words. (Click for all words.) 70 NYSE Amex INO 68 Chemokine Therapeutics 67 Rosetta Genomics Ltd. 66 Italy coul 65 Agios Pharmaceuticals 65 target Galectin receptors 65 Amgen discovers develops 65 CombinatoRx Incorporated CRXX 64 based pretargeting methods 64 optical biosensors 64 functional genomics proteomics 64 Sangamo ZFP technology 64 Small interfering RNAs 64 Inovio Biomedical Corporation 64 Inc. Nasdaq CLRT 63 Roche SIX RO 63 * Azixa 63 Inovio Pharmaceuticals Inc. 63 Receptos 63 NASDAQ SLP 63 Stem Cell Innovations 62 Inovio Pharmaceuticals 62 ZFN TM 62 G Protein Coupled 62 Alnylam maintains 62 therapeutic monoclonal antibodies 62 aTyr Pharma 62 Inc. NASDAQ CLDA 62 PRNewswire FirstCall Halozyme Therapeutics 62 Idera Pharmaceuticals 62 Pharsight Corporation 62 Nasdaq ENZN 62 ImmunoCellular Therapeutics Ltd. 62 Crucell NV NYSE Euronext 62 GlycosBio 62 Inc. OTCBB BVTI 61 commercial bioproduction 61 Nasdaq ENMD 61 Biomagnetics Diagnostics Corporation 61 Owlstone Nanotech Inc. 61 chemogenomics 61 NASDAQ CRXL 61 Nasdaq CRXL 61 Amira Pharmaceuticals 61 Cholesterol Breakthrough Dr. 61 OTCBB NEOP diversified 61 genes gene mutations 61 Inc. Nasdaq IMGN 61 ZFP Therapeutics 61 MorphoSys AG FSE MOR 61 TSX VENTURE ZMS FRANKFURT 61 Nasdaq ISIS 61 AviaraDx 61 Epitomics 61 LYON France BUSINESS WIRE 61 Therapeutic Competitors 61 addressing idiopathic pulmonary 61 Nasdaq MATK 61 Inc. Nasdaq NEXM 61 By HARVEY SIMPSON 61 VEGFR2 inhibitor 61 stem cell therapeutics 61 OTCBB ENTB 61 Exploit collaboration 61 microRNA miRNA 60 therapies Biogen Idec 60 NYSE Amex RNN 60 Medarex logo 60 NASDAQ LGND 60 specific ZFP Nucleases 60 Galenea 60 regarding Aethlon Medical 60 immunotherapeutics 60 lipidomics 60 novel RNAi therapeutics 60 HepaLife Technologies Inc. 60 SEQUENOM 60 poly ADP ribose polymerase 60 Healthnostics Inc. 60 Rosetta dependence 60 Initiates Phase II 60 Neogenix 60 ® bortezomib 60 Vical researches 60 Power3 Medical 60 Elixir Pharmaceuticals 60 TSX TKM 60 Illumina NASDAQ ILMN 60 Quark Pharmaceuticals 60 Simulations Plus Inc. 60 Inc Therapeutic Competitors 60 www.syntapharma.com 60 Alnylam dependence 59 NASDAQ OSIR 59 Perlegen Sciences 59 AEMD 59 microRNA therapeutics 59 Nasdaq XOMA 59 Source MDx 59 ImmuneRegen BioSciences Inc. 59 novel orally administered